1 / 8

Supplementary figure 1

Supplementary figure 1. Supplementary figure 2. Deletion. No CNA. Amplification. Anti-apoptotic BCL2 family members. Pro-apoptotic BCL2 family members. MCL1. Supplementary figure 3. A. B. C. Supplementary figure 4. Supplementary figure 5. Supplementary figure 6. A. B.

keona
Download Presentation

Supplementary figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplementary figure 1

  2. Supplementary figure 2 Deletion No CNA Amplification Anti-apoptotic BCL2 family members Pro-apoptotic BCL2 family members MCL1

  3. Supplementary figure 3 A B C

  4. Supplementary figure 4

  5. Supplementary figure 5

  6. Supplementary figure 6 A B

  7. Supplementary figure 7 S44563 (4 weeks) Untreated (4 weeks) Bleomycin (4 weeks) Bleomycin + S44563 (4 weeks) IR + S44563 (15 weeks) Untreated (15 weeks) S44563 (15 weeks) IR (15 weeks)

  8. Supplementary figure 8 IR*2 Excised tumor IR Tumor volume Time (days)

More Related